AI expands the repertoire of CRISPR-associated proteins for genome editing

Despite emerging clinical successes, current genome editors suffer from off-target effects and can trigger unwanted responses from the immune system, limiting their broader therapeutic applications. Writing in Nature, Ruffolo et al.1

 

https://www.nature.com/articles/d41586-025-02135-3       

 

By Pascal Notin